The Discounted Cash Flow (DCF) valuation of Ionis Pharmaceuticals Inc (IONS) is (98.35) USD. With the latest stock price at 61.17 USD, the upside of Ionis Pharmaceuticals Inc based on DCF is -260.8%.
Based on the latest price of 61.17 USD and our DCF valuation, Ionis Pharmaceuticals Inc (IONS) is a sell. selling IONS stocks now will result in a potential gain of 260.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.8% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (217.82) - (66.65) | (98.35) |
| Upside | -456.1% - -209.0% | -260.8% |